tiprankstipranks
Trending News
More News >
Abattis Bioceuticals Corp (ATTBF)
OTHER OTC:ATTBF
US Market

Abattis Bioceuticals (ATTBF) Income Statement

Compare
175 Followers

Abattis Bioceuticals Income Statement

Last quarter (Q4 2019), Abattis Bioceuticals's total revenue was C$226.27K, an increase of 9064.32% from the same quarter last year. In Q4, Abattis Bioceuticals's net income was C$-907.06K. See Abattis Bioceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 19Dec 18Dec 17Dec 16
Total Revenue
C$ 356.88KC$ 8.37KC$ 0.00C$ 0.00
Gross Profit
C$ 241.34KC$ 6.48KC$ 0.00C$ 0.00
Operating Expenses
C$ 4.26MC$ 15.84MC$ 6.36MC$ 2.31M
Depreciation and Amortization
C$ 109.01KC$ 37.36KC$ 90.95KC$ 130.03K
EBITDA
C$ -2.90MC$ -17.34MC$ -5.34MC$ -2.13M
Operating Income
C$ -3.96MC$ -17.37MC$ -6.36MC$ -2.31M
Other Income/Expenses
C$ 895.80KC$ -61.82MC$ -688.46KC$ -280.56K
Pretax Income
C$ -3.06MC$ -77.65MC$ -7.93MC$ -2.41M
Net Income
C$ -3.04MC$ -78.01MC$ -7.63MC$ -2.34M
Per Share Metrics
Basic EPS
C$ -0.01C$ -0.24C$ -0.05C$ -0.02
Diluted EPS
C$ -0.01C$ -0.24C$ -0.05C$ -0.02
Weighted Average Shares Outstanding
470.49M 322.64M 148.67M 95.00M
Weighted Average Shares Outstanding (Diluted)
470.49M 322.64M 148.67M 95.00M
Currency in CAD

Abattis Bioceuticals Earnings and Revenue History